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Highlights:  
• Mitophagy is a key mitochondrial quality control mechanism but how it is integrated with 
other quality control mechanisms still needs to be determined. 
• Mitophagy can occur under diverse conditions but whether distinct mechanisms operate 
for each of these remains unclear. 
• Three main molecular events occur during mitophagy initiation: (1) Fission from 
mitochondrial network, (2) mitochondrial priming with “eat-me” signals, and (3) 
phagophore recruitment to mitochondria to be engulfed. We still do not know if these 
events have to occur sequentially or in concert.  
• Impaired mitophagy has been associated with pathologies such as neurodegenerative 
diseases, but we still have a limited understanding of how it contributes to the diseases 
state and whether there are therapeutic opportunities to manipulate this process. 
 
Abstract:  
The elimination of mitochondria via autophagy, termed mitophagy, is an evolutionarily 
conserved mechanism for mitochondrial quality control and homeostasis. Mitophagy, 
therefore, has an important contribution to cell function and integrity, which extends to the 
whole organism for development and survival. Research in mitophagy has boomed in recent 
years and it is becoming clear that mitophagy is a complex and multi-factorial cellular response 
that depends on tissue, energetic, stress and signalling contexts. Yet we know very little of its 
physiological regulation and the direct contribution of mitophagy to pathologies like 
neurodegenerative diseases. In this review, we aim to discuss the outstanding questions (and 
questions outstanding) in the field and reflect on our current understanding of mitophagy, the 
current challenges and the future directions to take.     
 
1) What is mitophagy? 
Mitochondria are intricate organelles within every nucleated eukaryotic cell and provide key 
functions that enable complex organism survival. Mitochondria are metabolic hubs: they are 
the main generators of adenosine triphosphate (ATP) through oxidative phosphorylation 
(OXPHOS) as well as providers of key intermediates for fatty acid, hormone and amino acid 
biosynthesis [1]. Mitochondria are responsible for heme and iron-sulphur clusters, which are 
essential co-factors for many enzymes involved in diverse pathways from DNA repair to 
oxygen sensing. Mitochondria act as essential signalling platforms: not only do they control 
intracellular calcium levels [2], but also generate reactive oxygen species (ROS) [3], as well 
as regulate the innate immune response [4]. To top this off, mitochondria are also arbiters of 
cell death through the initiation of the intrinsic apoptotic pathway [5]. In order to carry out this 
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plethora of functions, mitochondria are structured in dynamic networks where mitochondria 
biogenesis, fission, fusion, transport and elimination are harmoniously integrated [6,7]. 
Signalling pathways regulating mitochondria homeostasis are therefore critical for cell survival 
and their dysfunction is associated with ageing as well as the rise of major diseases ranging 
from cancer to cardiovascular and neurodegenerative diseases [8]. 
 
What is mitophagy then and how does it relate to mitochondria? The mitochondrial network is 
surveyed by several mechanisms of mitochondrial quality control and mitophagy is one such 
pathway. In its simplest sense, mitophagy is the autophagy of mitochondria – which we define 
as the delivery of mitochondria, or parts of mitochondria, to lysosomes for degradation. One 
such route to lysosomes is via the macroautophagy pathway, which involves the engulfment 
of a mitochondrion by a double-membraned autophagosome [9]. Autophagosomes containing 
the sequestered mitochondrial cargo can then fuse with lysosomes, either directly or via 
endosomal fusion to form intermediate amphisomes [10]. The end point is the formation of an 
autolysosome, where the mitochondrion is degraded and recycled. It is this pathway that is 
the focus of this review article. Alternatively, mitochondrial turnover also occurs by budding 
mitochondrial pieces from the outer mitochondrial membrane to form mitochondrial-derived 
vesicles (MDVs), which then fuse with the endolysosomal system [11]. Ultimately though, as 
mentioned earlier, mitophagy is one of the several mechanisms for mitochondrial quality 
control. Mitochondrial network homeostasis may also involve proteasome-dependent 
degradation of mitochondrial proteins, mitochondrial proteases and chaperones or the 
mitochondrial unfolded protein response (mtUPR) [12,13]. However, the molecular and 
physiological interplay between mitophagy and all these other mitochondrial quality control 
pathways remains poorly understood. Indeed, in Drosophila melanogaster, canonical 
autophagy only accounts for around one-third of basal mitochondrial protein turnover [14]. 
Furthermore, mitochondrial proteins examined in this study also exhibited different basal 
autophagic turnover rates, which supports previous observations of selective mitochondrial 
protein degradation [15,16]. How mitochondrial proteins are selectively sorted and regulated 
within the network for mitophagic elimination is indeed an intriguing puzzle. This also 
emphasises our lack of understanding on how mitophagy harmonises within a bigger picture 
of mitochondrial biogenesis, function and dynamics for ultimate cellular response and function. 
For example, the coordinated regulation between mitochondria biogenesis and clearance 
have been previously studied in Caenorhabditis elegans to preserve energy homoeostasis, 
renew mitochondria and regulate longevity [17,18]. However, this coordination remains poorly 
understood in mammalian systems.  
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Over the past two years, the state-of-the-art mitophagy research has been exhaustively 
reviewed in many excellent articles [12,18–32]. As discussed below, our knowledge of how 
mitophagy functions is far from complete but it is rapidly expanding, as is evidenced by the 
almost exponential increase in publications that mention this keyword (Figure 1). Here, we 
aim to review the key questions that still remain regarding the molecular and physiological 
basis of mitophagy, emphasising the most recent discoveries and challenges. 
 
What have we learnt after 104 years?  
The idea of mitochondrial degradation (or “degeneration”) was first proposed in the early work 
on mitochondrial dynamics by Margaret and Warren Lewis in 1915  [33] (see Figure 1). Later 
in the century, observations using electron microscopy (EM) revealed the first instances of 
mitochondria within vesicles and lysosomes in rat tissues [34–36]. When Christian de Duve 
postulated the concept of cellular autophagy, the idea of mitochondrial autophagy flourished 
[37,38], and was further supported with reports describing mitochondrial autophagy in the 
muscle of metamorphosing Antheraea Polyphemus  [39], rabbit hearts under ischemia-
reperfusion injury [40] and during rat erythrocyte maturation [41]. The first indications for 
selectivity in the autophagic elimination of mitochondria happened in the early 2000s with 
reports indicating degradation of depolarised mitochondria [42–44]. To our knowledge, the 
term mitophagy was first used by Sidney Scott and Daniel Klionsky in 1998 [45], and became 
popularised by John Lemasters in 2005 [46]. 
 
The first mechanistic insights on how mitochondria were selectively targeted for mitophagy 
arose from landmark studies by the Klionsky, Ohsumi, Ney and Youle laboratories. The protein 
ATG32 was identified as a key mitophagy receptor in yeast [47,48]; meanwhile, BNIP3L/NIX 
was identified to play a critical role in mitophagy during mammalian erythrocyte differentiation 
[49,50]. In a distinct pathway, the ubiquitin E3-ligase Parkin was shown to regulate mammalian 
mitophagy following mitochondrial depolarisation [51] and the Parkin link was further 
strengthened following the key discovery of PTEN-induced kinase 1 (PINK1) as an upstream 
regulator of Parkin-mediated mitophagy [52–56]. The connection between these two proteins, 
both of which can be mutated in familial Parkinson’s disease, sparked the hypothesis of 
defective mitophagy as a potential cause of neurodegeneration. This fostered intense 
research on how the PINK1/Parkin pathway works at all levels [32,57,58]. However, over the 
subsequent years, other mitophagy receptors and signal mechanisms have been identified. 
The contribution each of them makes to the global turnover of mitochondria within an 
organism, or the context in which they operate, is far from clear [29].  
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The gold standard method to investigate mitophagy and autophagy over the years has been 
through the use of electron microscopy (EM) [59]. However, the development of simple, fast, 
selective and reliable reporter systems for assessing mitophagy has revolutionised the field. 
Two mitochondrial reporters were initially established to study yeast mitophagy in 2008: 1) 
Fusion of GFP with mitochondrial proteins, where mitophagy is analysed by western blot 
measuring the amount of cleaved GFP that happens in the vacuole [60], and 2) The Rosella 
reporter, which exploits the acid labile properties of fluorescence proteins GFP and DsRed 
(the former being sensitive to the acidic pH of the vacuole, while the latter is not). This 
assesses mitophagy as a change in colour to DsRed-only fluorescing mitochondria, which 
occurs upon delivery to the vacuole [61]. A similar fluorescent pH-biosensor system was used 
to generate the mito-QC reporter for assessing mitophagy in mammalian cells in vitro and in 
vivo [62,63]. Another fluorescent probe system, called mt-Keima, also uses a pH-sensitive 
protein with a pH-dependent shift in fluorescence excitation to assess mitophagy in cells and 
tissues [64,65]. An alternative reporter system, mito-Timer, relies on the fluorescence shift of 
DsRed1-E5 fluorophore from green to red over time. Although it does not directly measure 
mitophagy, it provides a powerful tool to monitor age and biogenesis of mitochondria [66]. The 
recent advent of mouse models expressing mt-Keima, mito-QC and mito-Timer has now 
provided the opportunity for in-depth physiological analysis of mammalian mitophagy 
regulation and its direct implication in disease conditions [62,65,67,68].  
 
2) Why degrade mitochondria through autophagy? 
Mitophagy is considered a cell survival mechanism responsible for clearing damaged, 
superfluous or aged mitochondria. It has the advantage over other degradation pathways in 
that a whole mitochondrion (including its membrane, proteins and nucleic acids) can be turned 
over in one go. While mitophagy has historically been considered a quality control mechanism 
to survey mitochondrial damage, we now know that cells degrade their mitochondria for 
multiple reasons and under different situations. For example, mitophagy has been observed 
under various circumstances ranging from the basal state to conditions of cell stress, and even 
during programmed cellular differentiation or cell death. Thus, mitophagy has evolved into a 
complex and multi-factorial cellular response that highly depends on the tissue, energetic, 
stress and signalling contexts.  
 
a. Why do cells undergo basal mitophagy? 
Mitophagy can occur under apparently normal conditions, in the absence of any overt stress. 
The exact function (or functions) of this so-called basal mitophagy is unclear, but the extensive 
nature of basal mitophagy across mouse and fly tissues was demonstrated using the 
fluorescent mitophagy reporters mt-Keima and mito-QC [62,65,69,70]. While the mainstream 
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idea is that cells undergo basal mitophagy as a general everyday mitochondrial network 
housekeeping mechanism, this mitophagy is neither homogenous across tissues nor between 
cells within the same tissue [62,69]. One example is the levels of basal mitophagy within the 
adult mouse kidney cortex, where proximal convoluted tubules (PCTs) are highly mitophagic, 
displaying a level much greater than that of adjacent distal convoluted tubules (DCTs), despite 
having a similar mitochondrial content [62]. This highlights an important context-dependent 
regulation of basal mitophagy, which remains unknown. More evidence of context-dependent 
basal mitophagy occurs in the eye. Mitophagy is surprisingly restricted in the retina, being 
localised to the outer nuclear layer (ONL), which is enriched in photoreceptor cell bodies 
[69,71]. Intriguingly, mitophagy in the ONL proceeds at similar rates during murine light or dark 
cycles [69]. In fact, we know very little about how the circadian clock regulates mitophagy, 
which has direct implications on autophagy and mitochondrial metabolic functions in general 
[72]. Could this basal mitophagy be selective or is it just a reflection of the level of 
macroautophagy in general? Using the mito-QC mouse and an almost identical autophagy 
reporter mouse expressing mCherry-GFP-MAP1LC3B, McWilliams  et.al. compared basal 
mitophagy and total macroautophagy side by side across eye tissues [71]. Surprisingly, high 
levels of total macroautophagy do not necessarily mean high levels of mitophagy, implying 
there is indeed autophagic selectivity in vivo. For example, mitophagy accounted for a 
significant amount of the total macroautophagy in the ONL, which was in stark contrast to lens 
epithelium or corneal stroma, where minimal mitophagy was observed despite high levels of 
total autophagy. Furthermore, these differences also highlight the specificity of the two, almost 
identical, reporter systems themselves for mitophagy and autophagy.  
 
The cellular triggers and the signalling driving basal mitophagy in vivo remain unclear, but 
metabolic demand and a baseline level of stress (as mentioned below) are likely to play a role. 
This is supported by the fact that greater levels of basal mitophagy exist in subsets of highly 
metabolic cells such as dopaminergic and retina photoreceptor neurons, cardiomyocytes or 
pancreatic acinar cells [69]. Ultimately, cellular signalling, tissue context (i.e. metabolism, 
nutrient/oxygen availability) and specific physiological functions will likely shape the 
requirement of certain cells to undergo basal mitophagy. 
 
b. Why do cells trigger mitophagy upon distinct stresses? 
Nutrient starvation, in particular amino acid starvation, is a well-established stress that 
activates autophagy. Therefore, cells facing prolonged starvation are thought to use 
autophagy to non-selectively degrade cellular components, including mitochondria to recycle 
and free-up amino acids [73]. However, under short periods of amino acid starvation, 
mitochondria are not degraded as they are required for energy production. In this case, 
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mitochondrial fission is restrained and a more fused mitochondrial network is generated, which 
hinders mitophagy by preventing the break-up of the network into “bite-size” fragments that 
are readily autophagocytosed [74–76]. Are cells then selectively regulating mitophagy during 
starvation? In yeast, nitrogen starvation induces bulk autophagy and mitophagy under a 
fermentable carbon source. However, yeast cultured under a non-fermentable carbon source 
blocked mitophagy, but not autophagy in general, upon nitrogen starvation [60]. This would 
suggest that indeed different regulation exists between mitophagy and other forms of 
autophagy triggered under stress. In a similar way, mammalian cells forced to rely on 
mitochondrial OXPHOS metabolism were also unable to engage mitophagy following 
mitochondria depolarisation or iron chelation [63,77–79]. It is of note that these treatments will 
affect the total mitochondrial pool, and mitophagy may be more permissive under OXPHOS 
conditions if only a subset of mitochondria are disrupted. Regardless, this implies that the 
cellular metabolic context could selectively modulate mitophagy under stress. Amino acid 
starvation was reported to increase reactive oxygen species (ROS) co-localising with 
mitochondria, suggesting a potential correlation with increased mitochondria activity or 
dysfunction [80,81]. In a similar scenario, some reports claim that higher mitochondrial 
respiratory activity promotes mitophagy [82,83], which could be protecting cells from a greater 
intrinsic mitochondrial stress. It is also possible that mitophagy induced during prolonged 
starvation is used as an adaptive response to renew and optimise the mitochondrial population 
in response to the reduced nutrient environment, or to release resources that are contained 
within mitochondria.  
 
Over the years, mitophagy has been studied as a mitotoxic damage response. Defective 
mitochondria can generate excessive amounts of ROS, consume ATP through the reversal of 
F1F0 ATPase activity, impair mitochondrial metabolic functions and trigger apoptosis [84]. 
Therefore, mitophagy aims to rapidly clear these dysfunctional mitochondria to protect cell 
integrity and this is thought to be especially relevant in post-mitotic long-lived cells such as 
neurons and cardiomyocytes. These likely need mitophagy during their long lifetime to ensure 
mitochondria homeostasis in the absence of the ability to “dilute” damaged mitochondria 
through cell divisions [19,25]. The selective photodamage of mitochondria provided the first 
insight on the mitophagic response to mitochondrial depolarization, where the autophagosome 
marker LC3 was recruited to damage sites [42,85]. However, extreme mitochondrial damage 
is often studied using chemicals such as protonophores (i.e. CCCP, FCCP) or selective 
electron transport chain (ETC) inhibitors (e.g. Rotenone, Antimycin A or Oligomycin A), which 
impair mitochondrial respiration and/or depolarise mitochondria [86,87]. These tools have 
been extensively exploited to gain mechanistic insights on how mitochondrial damage 
activates mitophagy and to explore its relevance to pathologies like Parkinson’s disease. 
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Indeed, toxins that cause Parkinsonian phenotypes in animal models like Paraquat or 6-
hydroxydopamine (6-OHDA) can also depolarise and damage mitochondria [87], although it 
is not clear whether they induce mitophagy. 
 
Mitochondrial function is tightly linked to oxygen availability, in particular for OXPHOS 
metabolism. Under hypoxic conditions, cells activate hypoxia-induced factor 1 (HIF1) 
signalling, which regulates gene expression to drive stress and metabolic adaptation 
programmes [88]. The lack of oxygen leads to inefficient mitochondrial respiration, 
mitochondrial stress and an energetic crisis [89]. For this reason, HIF1-signalling controls a 
metabolic switch to upregulate glycolytic genes, attenuate mitochondria respiration and trigger 
mitophagy [88,90,91]. In this context, mitophagy could be activated to refresh and adapt the 
mitochondrial network for the new hypoxic metabolic context. Alternatively, mitophagy could 
also be a protective mechanism against the mitochondrial stress caused during hypoxia, or 
the following the re-oxygenation process. For example, mitophagy has been suggested to 
contribute to brain and cardiac tissue protection following ischemia/reperfusion injuries 
[92,93]. Similarly, oxygen and glucose deprivation-reperfusion trigger mitophagy in cultured 
cortical neurons. Interestingly, this neuronal mitophagy is restricted to cell bodies and axonal 
mitochondria are transported here before undergoing mitophagy [94]. Similar observations in 
vivo showed how basal mitophagy primarily occurs in neuronal cell bodies, though whether 
autophagy was initiated in the axon for more distal mitochondria was not determined [62,69]. 
An alternative stress that mimics the hypoxia response, by stabilising HIF1a, is iron chelation. 
Depletion of iron is one of the most potent inducers of endogenous mitophagy tested in vitro 
[64,94]. While iron chelation has extensive repercussions for cellular functions such as DNA 
replication or mitochondria respiration, loss of iron neither depolarised mitochondria nor 
produced extensive ROS, as compared to conventional protonophores or ETC inhibitors [63]. 
Although the extent or type of mitochondrial damage caused by iron chelation is unclear, 
mitophagy could be activated as part of the metabolic reprogramming response induced by 
HIF1a signalling. Furthermore, it is possible that mitophagy could serve as a recycling 
response to iron deficiency by freeing iron stored within mitochondria. Intriguingly, C. elegans 
treated with an iron chelator or partial depletion of Frataxin (a protein involved in iron-sulphur-
cluster biogenesis) induced mitophagy, leading to an adaptative response that increased 
lifespan [96].   
 
Many forms of mitochondrial stresses have been associated with mitochondrial ROS 
production, which are natural products arising from mitochondrial oxidative metabolism. 
However, the unstable and variable nature of ROS makes their accurate measurement 
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challenging and not straightforward [97,98]. Low levels of ROS perform important signalling 
roles in processes, such as  skeletal muscle adaptive response to exercise, adipocyte 
differentiation, autophagosome formation and regulation of hypoxic and insulin signalling 
[3,81,99,100]. Excessive production and prolonged exposure to ROS can have severe 
consequences by increasing mitochondrial and nuclear DNA/RNA mutations, protein and lipid 
oxidation, and activation of cell death [8]. This raises the question as to whether ROS could 
trigger mitophagy directly. Some reports suggest that initiation of mitophagy was induced by 
mitochondrial ROS generated using the photoactivated dye KillerRed [101]. In yeast, 
mitophagy induced during post-log phase respiratory growth was partially suppressed in 
presence of the antioxidant N-acetyl cysteine (NAC) [47]. In contrast, other reports in 
mammalian cells postulated that ROS may not be the direct trigger of mitophagy, as mitophagy 
induced with CCCP or iron chelation were unaffected by the antioxidant NAC [51,63]. While 
the diverging observations could result from an organism-specific ROS response mechanism, 
the direct contribution of ROS in mitophagy remains a debatable question that requires further 
investigation. 
 
The recent development of mouse models with the mitophagy reporters, mito-Timer, mt-Keima 
and mito-QC, has opened a new avenue to investigate how physiological stresses impact 
mammalian mitophagy in vivo [29]. For example, mice subjected to exhaustive exercise had 
an increase in skeletal and cardiac muscle mitophagy [102,103]. The impact of several 
stresses to liver mitophagy was assessed by Sun et. al. using the mt-Keima reporter [65], 
where increased mitophagy was observed in mice subjected to prolonged hypoxia or 
mitochondrial stress derived from the proof-reading deficient mitochondrial polymerase G 
(PolgD257A). In contrast, in the same study, they reported that a high-fat diet caused a decrease 
in hepatic mitophagy. Temperature stress has also been shown to impact mitophagy. Mice 
subjected to chronic cold stress or Beta-3 adrenergic receptor agonist stimulation induced the 
formation of mitochondrial-rich beige adipocytes. Once these stimuli were withdrawn, the 
thermogenic beige adipocytes underwent a transition to white adipocytes that triggered 
mitophagy to eliminate superfluous mitochondria and aid this transition [104–106]. 
Interestingly, cold temperature stress has also been recently shown to trigger mitophagy in 
human fibroblasts after returning to a normal physiological temperature [107]. Until today only 
a few studies have been conducted to assess mitophagy under physiological stresses, 
although we anticipate intense research in this matter during the coming years. 
 
c. Why do cells require programmed mitophagy? 
Induction of mitophagy is not just a mechanism for cells to combat mitochondrial stress or 
damage. Mitophagy also helps in eliminating and renewing mitochondrial populations for 
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multiple developmental, metabolic and physiological proposes – this is termed programmed 
mitophagy [29]. There are instances where programmed mitophagy plays an important role 
during organism development. For example, during the later stages of erythrocyte maturation, 
the immature erythroblasts eliminate their mitochondria using mitophagy. After this process is 
complete, erythroblasts are enucleated and become mature erythrocytes [108]. The critical 
role of this mitophagy is highlighted by the fact that mice lacking the pro-apoptotic protein 
NIX/BNIP3L, which is essential for this process (see below), suffered from severe anaemia, 
reticulocytosis and erythroid-myeloid hyperplasia [49,50]. Programmed mitophagy can also 
operate at the very beginning of organism development with the selective elimination of 
paternal mitochondria following oocyte fertilization by sperm (a process termed as “allophagy” 
[109]). 
 
Cell differentiation often involves drastic metabolic reprogramming between glycolytic and 
OXPHOS metabolism from one cellular state and another [110]. In a similar way to hypoxia, 
these metabolic switches are thought to activate mitophagy for mitochondrial network 
remodelling and homeostasis in response to metabolic demands. One example was reported 
in cardiomyocyte maturation. In this study, cardiomyocyte mitophagy occurring in the perinatal 
heart was proposed to be instrumental in switching out fetal mitochondria, which are optimised 
for carbohydrate-driven OXPHOS, with more mature adult mitochondria that undergo fatty 
acid-driven OXPHOS [111,112]. This phenomenon may not be restricted to the heart and may 
occur during muscle differentiation in general [113]. Another example of metabolic switching 
occurs in stem cells where pluripotent and human embryonic stem cells heavily rely on 
glycolytic metabolism, while somatic and differentiated cells rely on OXPHOS metabolism. In 
this context, mitophagy and mitochondrial dynamics have emerged as an important factor for 
stem cell fate, differentiation and induced pluripotent stem cell generation (iPSC) [110,114–
118]. However, the current understanding of how mitophagy is regulated in stem cells and 
iPSC remains limited.  
 
As well as associating with metabolic switches, developmentally programmed mitophagy may 
also drive them, in particular when promoting a shift towards glycolysis. This was shown to 
happen when Retinal ganglion cells (RGCs) differentiated from neuroblasts following hypoxia 
or in macrophage differentiation [27,119]. In a different context, mitophagy can also contribute 
to cancer cell survival under mitotic arrest. When mitosis is blocked, cancer cells use 
mitophagy to clear their mitochondria and create an ATP-deficiency crisis, which leads to 
AMPK activation and upregulation of glycolysis [120].  
 
 
 11 
d. Can cells use mitophagy to die?  
Autophagy and mitophagy are generally known by their protective and cell survival functions. 
However, autophagy has also been implicated in inducing cell death, with important functions 
during embryo development and cancer [121]. While autophagic cell death has been 
extensively studied, the contribution of mitophagy to this, termed as lethal mitophagy, remains 
enigmatic and its physiological contribution poorly understood. One of the few instances of 
lethal mitophagy suggested that ceramide, a bioactive sphingolipid, is responsible for 
mediating caspase-independent cell death via excessive mitophagy [122]. Interestingly, there 
are hints for a potential tumour suppressor role of lethal mitophagy, as the growth of xenograft-
generated tumours in mice was suppressed after overexpressing CerS1, which is involved in 
the synthesis C-18 ceramide [122]. 
 
3) How are mitochondria “eaten” during mitophagy?  
Multiple signalling events converge for the execution of mitophagy. On one hand, this requires 
the mitochondria to be specifically marked or primed in some way depending on the cellular 
need, stimuli or damage. This could be considered an “eat-me” signal. And on the other hand, 
mitochondria also need to be isolated from the network, to either decrease their size to be 
engulfed by the autophagosome or protect the rest of the network integrity to avoid further 
damage. Therefore, the initial stages of mitophagy comprise of three main steps: a) 
Mitochondrion isolation or fission from the network, b) Marking or priming this isolated 
mitochondrion, and c) Recruitment of phagophore membranes to engulf the primed 
mitochondrion (Figure 2). Whether these are sequential events or happen in concert is not yet 
clear. For example, mitochondrial fission from the network is required for mitophagy and this 
can be driven by DRP1-dependent machinery prior to engulfment [29], but in contrast, the 
forming phagophore can also mediate mitochondrial isolation directly, independently of DRP1 
[95].  
 
a. What are the mitochondrial “eat-me” signals?  
The so-called autophagy cargo receptor proteins are key in determining how a cellular 
component is engulfed by a forming autophagosome and the reader is referred to recent 
reviews for a more in-depth perspective of this class of proteins [21,30]. It is therefore no 
surprise that these proteins are essential for mitophagy. In yeast, the mitochondrial protein 
ATG32 is currently the only mitophagy receptor identified to selectively prime mitochondria for 
degradation. When mitophagy is stimulated, either through nitrogen starvation or long-term 
respiratory growth, this single-pass OMM protein is upregulated and recruits the nascent 
autophagosome via direct interaction with the selective-autophagy adaptor ATG11 and ATG8 
[47,60,123]. In metazoans, the number and type of mitophagy receptors have evolved to allow 
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fine-tuning of mitophagy to the different stimuli and cellular contexts mentioned above. In 
general, forming autophagosomes (or phagophores) are recruited to mitochondria through two 
main types of “eat-me” signals that depend on the requirement of the receptor to bind ubiquitin 
or not (Figure 3). Whether each type of receptor functions in a distinct pathway or there is co-
operation between them remains to be determined. 
 
i) Ubiquitin-dependent mitophagy receptors:  
Classically, ubiquitin-dependent mitophagy has primarily referred to the PINK1/Parkin 
mitophagy pathway. This pathway requires the mitochondrial-associated Ser/Thr kinase 
PINK1 and the RBR E3-ubiquitin ligase Parkin, both of which are mutated in some forms of 
hereditary Parkinson’s disease (PD). This is the most studied and understood mitophagic 
pathway, at least in terms of mechanism. This area has also been extensively reviewed (see 
[12,30,32]) and is summarised briefly here (see Figure 3A). When mitochondria are 
depolarised, PINK1 is stabilised and accumulates in the outer mitochondria membrane (OMM) 
[52,53]. This stabilisation results in activation of PINK1 that in turn drives mitophagy through 
two parallel processes: a) phosphorylation of ubiquitin at serine 65, present at a basal level at 
the mitochondrial surface; and b) mitochondrial recruitment and phosphorylation of Parkin 
(also at serine 65) [124–128]. Phosphorylated Parkin and its interaction with phospho-ubiquitin 
allow Parkin to achieve a fully active conformation [129,130]. This drives ubiquitylation of 
multiple substrates in the OMM [131]. The continuous PINK1-dependent phosphorylation of 
ubiquitin chains creates a feed-forward loop that recruits autophagy receptors to the 
mitochondria [132–135]. This ubiquitylation of mitochondrial surface proteins does not 
exclusively rely on Parkin, as other E3-ubiquitin ligases, such as MUL1, ARIH1, SIAH1, 
SMURF1 and Gp78, have been described to cooperate with, or act alternatively, to Parkin 
activity downstream of PINK1 [25]. The prevailing model for how autophagy receptors function 
proposes that they bridge ubiquitylated cargos with forming autophagosomes via their 
ubiquitin-binding domains and LC3-interacting region (LIR) motifs respectively [30]. Three 
receptors, NDP52/CALCOCO2, Optineurin (OPTN) and partially TAX1BP1, were shown to 
play an essential role during PINK1/Parkin mitophagy [133]. Interestingly, the phospho-
ubiquitin signature generated by PINK1 was sufficient to recruit NDP52 and OPTN receptors 
to mitochondria independently of Parkin [133]. In parallel, receptor binding to mitochondrial 
ubiquitin chains is enhanced by TANK-Binding kinase 1 (TBK1) phosphorylation, which 
interacts with OPTN and NDP52 to establish a second feed-forward mechanism [134]. The 
role of the archetypal autophagy receptor, p62/SQSTM, in PINK1/Parkin mitophagy is less 
clear as contradictory evidence suggest it is dispensable [133] or required [54,136]. In 
contrast, p62 has been also reported to act upstream of the ubiquitylation cascade to mediate 
basal hepatocyte mitophagy independently of Parkin [137]. In DRP1 knock out hepatocytes, 
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p62 accumulated in mitochondria and promoted mitochondria ubiquitylation by interacting with 
Keap1 and recruiting the E3-ligase RBX1 [137].  
 
In addition to receptor recruitment, ubiquitylated OMM proteins are also targets for 
proteasomal-mediated degradation; a process termed as outer mitochondrial membrane-
associated degradation (OMMAD) [138]. The selective elimination of mitochondrial proteins 
plays an important role during mitophagy induction to regulate mitochondria dynamics such 
as transport and fusion. For example, following mitochondria damage and PINK1/Parkin 
activation, Mitofusin 1 and 2 (MFN) are rapidly ubiquitylated by Parkin to mark them for 
proteasomal degradation. This has important implications for Parkin-dependent mitophagy: a) 
it inhibits damaged mitochondria fusion with the network, facilitates fragmentation and 
activation of mitochondria fission [139], and b) it destroys mitochondria-ER contact sites 
mediated by MFN2 tethering functions and thus facilitates mitophagy [140]. In a similar way, 
the mitochondrial transport regulator MIRO1/RHOT1 is also degraded after PINK1 activation 
to impair targeted mitochondrial motility [141].  
 
OMMAD may also play a more direct role in mitophagy activation. This large-scale extraction 
of ubiquitylated proteins is thought to lead to OMM rupture and damage [142]. This in turn 
leads to the exposure of inner mitochondrial proteins that can signal mitophagy. For example, 
proteasome-dependent OMM rupture during Parkin-mediated mitophagy facilitates the 
exposure of the inner mitochondria membrane mitophagy receptor, Prohibitin 2 (PHB2). 
Following OMM breakage, PHB2 can interact with the forming phagophore via its LIR motif 
[143]. While PHB2 function suggests a dual model of phagophore membrane recognition with 
the cooperation of both OMM and IMM receptors, it could also serve as an alternative stress-
response signal responsible for monitoring internal mitochondria integrity. Related to this, 
recent work has shown that the normally mitochondrial matrix localised NIPSNAP1 and 
NIPSNAP2 proteins are essential for Parkin-mediated mitophagy and play a key role in 
receptor recruitment [136]. Taken together, this raises the intriguing possibility that the function 
of mitochondrial protein ubiquitylation may be to cause OMM damage in order to reveal the 
receptor-binding “eat-me” signals. 
 
Ubiquitylation is reversible through the action of deubiquitylase enzymes (DUBs), and these, 
such as USP30, USP35 and USP15, have been linked to mitophagy. USP30 is the only DUB 
constitutively associated with the mitochondrial surface, where it deubiquitylates Parkin 
substrates to inhibit Parkin-dependent mitophagy [144,145]. Once Parkin is activated, USP30 
activity is overwhelmed and impaired by phospho-ubiquitin chains [146]. Interestingly, USP30 
has recently been shown to regulate basal mitophagy [147]. Depletion of USP30 up-regulates 
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basal mitophagy, which is dependent on PINK1 function but not Parkin. This suggests that a 
basal level of mitochondrial ubiquitylation is indeed a key signal for mitophagy regulation. 
USP30 has also been reported to localise at peroxisomes and to regulate basal and stress-
induced pexophagy. Peroxisome function and biogenesis are closely interlinked with 
mitochondria [148] and ubiquitylation of peroxisomal proteins also occurs during pexophagy 
[149]. Therefore, it could be speculated that the selective degradation of both organelles is co-
regulated, and USP30 is potentially a common regulatory node. Another example of organelle 
communication during mitophagy occurs between ER and mitochondria. BCL2 and FKBP8 
were reported to translocate from mitochondria to the ER upon mitochondrial damage and 
mitophagy induction, thus escaping lysosomal turnover where they can initiate an anti-
apoptotic response [150]. FKBP8 itself is interesting as it can serve as a ubiquitin-independent 
mitophagy receptor despite translocating to the ER [151]. It is well known that organelle 
dynamics and functions are interlinked; however, it remains largely unexplored how mitophagy 
signalling interplays with other forms of selective autophagy or organelle functions to 
coordinate cell responses. 
 
The PINK1/Parkin pathway has, quite rightly, dominated the field of mitophagy over recent 
years and there is no doubt that this pathway can trigger mitophagy under the right conditions. 
It is also evident that PINK1 and Parkin clearly perform important cellular functions given that 
their mutation results in Parkinson’s disease. However, the way that this pathway has been 
primarily studied over the years (in transformed cell cultures overexpressing vast amounts of 
Parkin and coupled with harsh chemicals that depolarise mitochondria to cause dramatic 
mitochondrial damage) has raised debate as to when such a scenario may be relevant 
physiologically [19,152,153]. Mainly strong depolarising agents have been reported to 
promote PINK1 activation, in contrast to Parkinsonian neurotoxins [124]. Though the 
accumulation of misfolded protein in the mitochondrial matrix has also been shown to trigger 
PINK1/Parkin mitochondrial recruitment without apparent mitochondrial depolarization [154]. 
This may represent a more physiological stimulus. While these in vitro experiments have been 
instrumental for determining the mechanism of PINK1/Parkin-driven mitophagy, solid 
evidence for when this pathway operates in vivo is still in short supply. However, it has become 
clear in recent years that it is not the major mitophagy pathway operating in vivo under normal 
lab-based conditions. For example, loss of PINK1/Parkin pathway in flies and mice expressing 
either mt-Keima or mito-QC reporters failed to show any notable difference in steady-state 
basal mitophagy [69,70,155]. The pathway or pathways responsible for these instances of 
mitophagy remain to be determined. Likewise, loss of the key PINK1 phosphorylation site for 
Parkin activation, serine 65, resulted in the loss of endogenous Parkin activity in cultured 
cortical neurons and selective locomotor impairments with mild mitochondrial defects in mice 
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[155]. However, neither basal mitophagy in vivo nor mitochondrial depolarisation-induced 
mitophagy in patient-derived fibroblasts were altered. Using a more general mitochondrial 
stress, Sterky et. al. crossed Parkin knock out mice with mice lacking Tfam in dopamine 
neurons (MitoPark model). While MitoPark mice exhibit parkinsonism phenotype, the Parkin 
knock out did not exacerbate the phenotype. In addition, overexpressed Parkin in dopamine 
neurons in vivo failed to recruit to mitochondria despite the mitochondrial stress [156]. In 
contrast to this study, Pickrell et. al. used the mutator mouse model (PolgD257A) to drive 
mitochondrial DNA mutations and increase mitochondrial stress. While dopamine neurons 
indeed degenerated with age in the absence of Parkin and the mice had neurodegenerative 
phenotypes, it was unclear from the study whether the defective mitophagy was the root of 
the problem [157]. Likewise, in the heart, depletion of Parkin has been shown to increase 
mouse susceptibility to myocardial infarction and under these conditions the mitochondria 
exhibited an abnormal morphology that is consistent with a mitophagy defect [158]. More 
recently, using the mt-Keima reporter in PINK1 knockout mice, Sliter et. al. showed that 
although mitophagy still occurred, its levels were diminished in the heart following extreme 
exhaustive exercise (though, it was uncertain whether mitophagy levels in nigrostriatal 
dopamine neurons were also altered) [103]. Thus, it seems possible that PINK1/Parkin 
mitophagy only becomes relevant under specific high-stress contexts. Overall, the 
physiological significance of the PINK1/Parkin pathway and its contribution to mitophagy in 
vivo remains a very important challenge to clarify in the coming years, in particular in 
determining what these physiological stimuli are. Perhaps, with respect to PD, mitophagy-
independent functions of PINK1 and Parkin could also play a critical role.  
 
ii) Ubiquitin independent mitophagy receptors:  
A certain class of cargo receptors bypass the need for ubiquitin to link the forming 
autophagosome with its cargo. For mitophagy, these ubiquitin-independent receptors are 
OMM proteins containing LIR motifs that directly recruit the autophagosomal membrane (see 
reviews [25,26,29] and Figure 3B). ATG32 is the only mitophagy receptor in yeast and its 
signalling mechanism is somewhat evolutionary conserved in mammals where there are 
currently several proteins identified: BNIP3, NIX/BNIP3L, FUNDC1 and BCL2L13. The 
primary mode for these proteins to mediate mitophagy is thought to be in mediating the direct 
interaction of the mitochondrion with the nascent autophagosome. The process is modulated 
at two different levels: 1) Protein abundance: For example, BNIP3 and NIX are under 
transcriptional control by upstream mitophagy signalling [90]. Once a cue for mitophagy 
happens, these receptors are upregulated several-fold and increase their presence in the 
OMM. It remains unclear how (or if) selectivity, in terms of mitochondrial targeting of receptors, 
occurs in these instances. 2) Post-translational modifications: mitochondrial receptor function 
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is modulated primarily by phosphorylation events that facilitate or enhances the receptors’ 
capacity to interact with LC3/GABARAP proteins to drive mitophagy. For example, ATG32 is 
phosphorylated near the LIR motif, potentially by CK2, to facilitate the key interaction with the 
adaptor protein ATG11 [159,160]. Similarly, NIX is also phosphorylated by an unknown kinase 
to strengthen the interaction with LC3/GABARAP proteins [161]. In contrast, FUNDC1 is 
inhibited under basal conditions by CK2/Src phosphorylation of the LIR motif [162,163]. In this 
case, mitophagic activity is facilitated by PGAM5 phosphatase activity and the FUNDC1-ATG8 
interaction is strengthened by ULK1 phosphorylation [164]. FUNDC1 can also be ubiquitylated 
and proteasomally degraded to limit the mitophagy response [165]. Although phosphorylation 
is currently the main mechanism of regulation, other still uncharacterised post-translation 
modifications could be important for fine-tuning receptor activity. Overall, the upstream 
regulation of mitophagy receptors and the inherent selectivity for marking mitochondria 
remains poorly understood.  
 
In terms of mitophagy pathways, ubiquitin-independent mitophagy receptors have been 
described to act in different contexts and stimuli, including programmed mitophagy or stress-
induced mitophagy (during hypoxia or mitochondrial damage with depolarising agents [29]). 
For example, as mentioned earlier, NIX is important in regulating programmed mitophagy 
during erythrocyte maturation [49,50,166] or to drive metabolic reprogramming during RGCs 
or macrophage differentiation [119]. In parallel, FUNDC1, NIX and BNIP3 are known to be 
upregulated during hypoxia and regulate hypoxia-induced mitophagy [90,162]. Strikingly, 
mitophagy receptors may be exploited by the intracellular bacterial pathogen Listeria 
monocytogenes for survival. The virulence factor listeriolysin O triggers mitophagy in infected 
macrophages by inducing oligomerization of a new mitophagy receptor, Nod-like receptor X1 
(NLRX1), which localises to mitochondria and contains canonical LIR motifs [167]. It is thought 
that the bacterial-induced mitophagy reduces ROS production to aid its intracellular survival. 
 
The regulation of mitophagy by mitochondrially-associated receptors is evolutionarily 
conserved from yeast to humans and physiologically relevant in mammals under different 
scenarios [29]. Thus, it could be hypothesised that mitophagy receptors are the ancestral 
mechanism for mitophagy, while the PINK1/Parkin pathway emerged later as direct on-site, 
fast and selective response mechanism - potentially in parallel with xenophagy [21]. 
Interestingly, when NDP52 is forced to act as canonical ubiquitin-independent mitophagy 
receptor, by ectopically tethering it to mitochondria with chemical inducible dimerization, the 
receptor can then bypass the PINK1/Parkin signalling cascade and directly recruit ULK1 
complex to trigger mitophagy [168]. Furthermore, mitochondrial depolarization in 
PINK1/Parkin-deficient cells can still be rescued by NIX-mediated mitophagy, as 
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overexpression of NIX restored CCCP-induced mitophagy in human fibroblast-derived from 
Parkin or PINK1-related PD patients [169]. As discussed, while ubiquitin dependent and 
independent receptors have been shown to mediate mitophagy in different contexts and 
stresses, the potential cooperation and crosstalk between both mitophagy signalling 
mechanisms require further study.    
 
An alternative mechanism of mitochondrial priming utilises lipids instead of proteins as 
mitophagy receptors, and this situation may be analogous to the PHB2/NIPSNAP mechanism 
mentioned above. Cardiolipin (CL) is a lipid exclusively found in the IMM with important roles 
in regulating mitochondrial respiration and dynamics [170]. Mitochondrial damage can result 
in translocation of CL from IMM to OMM, or at least allow exposure to the cytosol. On one 
hand, translocation to the mitochondrial surface leads to CL oxidation, which facilitates 
mitochondrial membrane permeability, cytochrome C realise and apoptosis [171]. On the other 
hand, the negative-charged head group of CL can interact with the basic amino acids in the 
N-terminal domain of LC3 proteins decorating autophagosomes [170], priming mitochondria 
for mitophagy. It was reported that the externalisation of CL could be regulated by the IMS 
enzyme nucleoside diphosphate kinase NDPK-D, suggesting this mitophagy pathway could 
be further regulated [172]. However, it remains uncertain if CL-mediated mitophagy is a 
parallel pathway or cooperates with other mitophagy signalling events mediating phagophore 
recruitment and expansion. CL may not be the only mitophagy receptor lipid as lethal 
mitophagy, mentioned earlier, is regulated by sphingolipids [122]. During lethal mitophagy, 
C18 ceramides follow a similar mechanism to CL and recruit phagophore membranes to the 
OMM by direct interaction with LC3. It is possible that the use of mitochondrial lipids in 
mitophagy is more widespread; however, how, when and which lipids in the mitochondrial 
double membrane system could directly contribute to mitophagy, outside of the two 
mentioned, has been largely overlooked. For example, Ivatt et.al. reported in flies and human 
cells that PINK1 stabilisation was impaired under the loss of sterol regulatory element binding 
proteins (SREBPs) [173]. SREBPs are involved in the regulation of cholesterol and 
phospholipid synthesis, suggesting that defective lipid synthesis could lead to abnormal 
mitochondrial lipid composition and impaired PINK1 dependent mitophagy. Although, off-
target consequences of depleting lipid synthesis cannot be discarded at this point. Of interest, 
genome-wide association studies identified SREBF1 as a risk locus for idiopathic PD [174].  
 
b. How is the autophagy machinery engaged to eat mitochondria? 
The ultimate goal for any mitophagy priming mechanism is to recruit the autophagy machinery 
to nucleate the mitochondrion-engulfing autophagosome. Recruitment and activation of the 
ULK1 protein kinase complex (comprising of ULK1, ATG13, FIP200 and ATG101) is one of 
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the earliest and essential events in triggering autophagosome formation and it is thought that 
this is also a key requirement for mitophagy initiation [9,133,168,175–177]. For example, 
ULK1 knock out mice accumulated mitochondria in erythrocytes due to impaired mitophagy 
[175]. How then is the ULK1 complex recruited to mitochondria during mitophagy? It appears 
that the receptor proteins could play an essential role in this mechanism. 
 
During PINK1/Parkin mitophagy, the mitochondrial receptors NDP52 and OPTN were shown 
to recruit the ULK1 complex and early autophagy markers such as WIPI1 and DFCP, which 
were proposed to nucleate autophagosome formation [133]. For NDP52 at least, ULK1 
recruitment is mediated by direct interaction with the ULK1 complex member FIP200, which 
in turn is facilitated by TBK1 activity [168]. As mentioned above, the forced recruitment of 
NDP52 to mitochondria is sufficient to directly recruit the ULK1 complex and trigger mitophagy 
[168]. Although OPTN and TAX1BP1 are also important for PINK1-mitophagy, it is unclear 
whether they can also recruit ULK1. As with the ubiquitin-dependent receptors mentioned 
above, ULK1 has also been shown to interact directly with “ubiquitin-independent” FUNDC1 
and BCL2L13 on the OMM to initiate autophagosome formation [164,178]. However, whether 
other receptors such as NIX or BNIP3 also directly recruit the ULK1 complex remains to be 
determined. 
 
Over the years, it was thought that the primary function of autophagy and mitophagy receptors 
was to interact with ATG8/LC3/GABARAP proteins, using their LIR motifs, and in this way 
recruit the nascent autophagosome. However, the actual role of ATG8/LC3/GABARAP 
proteins in autophagosome formation at mitochondria (a mitophagosome) may be more 
complex. Firstly, the LC3/GABARAP proteins are not essential for all forms of mitophagy, as 
mice lacking core genes for the ATG8 conjugating system, such as ATG5 and ATG7, can still 
clear mitochondria during erythrocyte maturation [179,180]. Furthermore, in cells depleted of 
all six mammalian LC3/GABARAP proteins, mitochondria can still be incorporated into forming 
autophagosomes, though the process is somewhat impaired. Interestingly, this study revealed 
that GABARAP was required at a later step for the fusion of the mitochondrion-containing 
autophagosomes with lysosomes [181], which has also been described for autophagosomes 
in general [182]. 
 
Though mitophagy receptors can interact with both ULK1 and LC3/GABARAP proteins, they 
may be recruited independently to mitochondria during mitophagy [95,168,176]. Recent 
evidence suggests that the canonical function of LIR motifs in autophagy receptors is perhaps 
not to selectively link ubiquitylated OMM proteins to LC3/GABARAP proteins on the forming 
autophagosome [183]. In the proposed model, the LC3/GABARAP proteins recruit receptors 
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to form autophagosomes independently of ubiquitylation, which results in an LC3/GABARAP-
dependent positive feedback loop to amplify the Parkin-driven mitophagic response. It is 
possible that a similar mechanism also occurs with ubiquitin-independent receptors, but 
further work is needed to confirm this. Intriguingly in Arabidopsis, ATG8 contains a conserved 
ubiquitin-interacting motif on the opposite face from the canonical ATG8-interacting motif 
[184]. This opens an avenue for potential new mitophagy receptors or alternative mechanisms 
of regulation [184]. 
 
c. How does Rab GTPase signalling regulate mitophagy? 
As discussed above, autophagosomes fuse with the endocytic system and ultimately 
lysosomes. This process of autophagy mirrors many aspects of the classical endocytosis and 
phagocytosis pathways and has been reviewed previously [10,185]. Once an autophagosome 
has formed, it can utilise the same machinery as endosomes, namely tethering complexes 
and SNAREs to ultimately regulate fusion with lysosomes. The GTPase Rab7 plays a key role 
here [10]. The Rab family of small GTPases, of which there are close to 70 members in 
humans, are fundamental organisers of intracellular membrane trafficking. They confer 
membrane identity and ensure that membrane cargoes are transported, docked and fused to 
the correct destination [186,187]. Rab GTPases work as molecular switches relying on their 
capacity to bind GTP and GDP; they are inactive when bound to GDP (with a primarily 
cytosolic localisation) and active, and able to bind effector proteins, when bound to GTP (with 
a membrane localisation). This Rab cycle is tightly controlled by Rab-GEFs and Rab-GAPs. 
The guanine-nucleotide-exchange factors (GEFs) regulate Rab activation by promoting the 
exchange of bound GDP for GTP; meanwhile, the GTP-hydrolysis activating proteins (GAPs) 
inactivate Rabs by stimulating their ability to hydrolyse GTP into GDP.  
 
It has now become evident that Rabs can regulate autophagy, and hence mitophagy, at 
multiple points, prior to the lysosomal fusion mentioned above. Intriguingly, Rab7 may also 
play a role in mitophagy initiation during Parkin-mediated mitophagy (Figure 4A). These 
studies have built up two complimentary models to describe how incoming ATG9a-positive 
vesicles contribute to autophagosome expansion [188–192]. 1) Ubiquitylation of OMM 
proteins, downstream of PINK1 and Parkin activation, leads to the direct recruitment of 
RABGEF1 (a Rab5-GEF). This creates a signalling platform to initiate the classical Rab 
conversion pathway observed during endosome maturation [193]. Recruitment of Rab5 
engages the Rab7 effector complex MON1/CCZ1, which in turn leads to the recruitment and 
activation of Rab7. Then, Rab7 functions to direct ATG9a vesicles to the primed mitochondria, 
which provides essential membranes to mediate mitophagy [188]. This Rab cascade and 
Rab7 activity are negatively regulated by the Rab7-GAPs, TBC1D15 and TBC1D17, which 
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are recruited to mitochondria by interacting with Fis1 [189]. These Rab7-GAPs also interact 
with LC3/GABARAP proteins coating the autophagosomes via a LIR motif, and regulate Rab7 
activity to constrain phagophore formation to the target mitochondria [189]. Depletion of 
TBC1D15 and TBC1D17 leads to Rab7 accumulation on mitochondria and an abnormal 
accumulation of autophagosome-like structures that delays and impedes the clearance of 
depolarised mitochondria [188,189]. 2) The retromer complex, an endosomal protein recycling 
complex, consisting of a trimer of VPS26, 29 and 35 as well as a dimer of distinct sorting 
nexins, also has a pivotal role in regulating Rab7 localisation to mitochondria for effective 
Parkin-dependent mitophagy [191]. The interaction of VPS29 with the Rab7-specific GAP, 
TBC1D5, enables the retromer complex to control Rab7 localisation, activity and mobility. 
TBC1D5 activity inactivates Rab7 to release it from endo-lysosomal membranes and generate 
pools of inactive Rab7 that can re-localise to mitochondria, endosomes or Trans-Golgi network 
for other functions, including mitophagy. This Rab7 regulation by retromer during Parkin-
mediated mitophagy is independent of the retromer’s classical cargo sorting function and is 
thought to allow the proper sorting of ATG9a vesicles to autophagosome formation sites 
around primed mitochondria. When TBC1D5 and retromer complex functions are lost, 
hyperactivated Rab7 clusters around lysosomes and is unable to regulate mitophagy. In this 
case, ATG9a accumulates in the Trans-Golgi network, as is also observed in VPS35 PD-
related mutants [194]. Rab7 function during Parkin-mediated mitophagy is also regulated via 
its phosphorylation at serine 72 by TBK1. While this phosphorylation is critical to regulate 
Rab7-dependent recruitment of ATG9a vesicles to depolarised mitochondria, it also facilitates 
the recruitment of FLCN/FNIP1 complex (a proposed Rab-GEF). Though FLCN/FNIP1 
appears necessary for mitophagy, it does not regulate ATG9a-positive vesicle recruitment. 
Interestingly, HeLa cells lacking TBK1 have a delayed induction of Parkin-driven mitophagy 
[168]. Considering Rab7-regulation of autophagosome formation by TBK1, it could be 
speculated that this delay is caused by defective establishment and expansion of the 
phagophore at the mitophagic site. It remains to be clarified if this Rab7-dependent 
mitophagosome expansion also occurs in other mitophagy signalling contexts independently 
of PINK1 or Parkin.  
 
Intriguingly, Rab7 has also been reported to regulate mitochondrial fission via lysosome-
mitochondria contact sites. These contact sites were untethered under hyperactive Rab7 
conditions, which blocked mitochondrial fission. However, TBC1D15 GAP activity could 
downregulate Rab7 activity and preserve lysosome-mitochondria contact sites, which 
facilitated mitochondrial fission. Although mitochondrial fission is a requirement for and often 
precedes mitophagy, the mitochondria contacting lysosomes were not observed to take part 
in mitophagy [195]. Mitochondrial fission and dynamics have also been associated with Rab32 
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and the SNARE protein Syntaxin-17 (STX17), specifically at ER-mitochondria contact sites, 
where they regulate DRP1 activity [196]. STX17 has further links to mitophagy given that it 
has been implicated in regulating fusion of autophagosomes with lysosomes [10,197], as well 
as mediating MDV-lysosomal fusion [198]. STX17 may also regulate earlier stages of 
mitophagy as it has been recently linked with autophagosome formation following TBK1 
phosphorylation [199]. In this context, STX17 has been reported to regulate Parkin dependent 
and independent mitophagy from ER-mitochondrial contact sites [200,201]. 
 
In addition to Rab7, other Rabs have also been directly implicated in mitophagy. Rab35 was 
shown to be recruited to depolarised mitochondria downstream of Parkin to aid in NDP52 
receptor recruitment, which was enhanced by TBK1 and negatively regulated by the Rab-GAP 
TBC1D10A [202]. Another example is the role of Rab11a in recruiting WIPI2 at endosomes to 
regulate the ATG8-conjugation system for phagophore expansion. Although this was not 
shown to be specific for mitophagy, Rab11a positive membranes were found to engulf 
mitochondria during iron chelation-induced and depolarisation-induced mitophagy [203]. 
Furthermore, Rab8a/b and Rab13 can be indirectly phosphorylated by PINK1 after 
mitochondrial depolarisation at ser111 to promote Rab inactivation [204]. The kinase or 
phosphatase downstream of PINK1 are still unknown, and it remains unclear whether PINK1 
regulation of these Rabs contributes to mitophagy or other functions. 
 
Another example of mitophagy regulation by Rabs occurs during ATG8-independent 
autophagy and mitophagy (Figure 4B). In cells lacking the core ATG8 conjugating machinery, 
Rab9 (as well as ULK1) was shown to regulate autophagosome formation by fusing isolated 
membranes with vesicles derived from Trans Golgi Network and late endosomes. This Rab9-
dependent autophagic pathway was implicated in programmed mitophagy during erythrocyte 
maturation [179]. More recently, Saito et. al. used the mt-Keima mouse model to show that 
mitophagy induced in cardiomyocytes during ischemia or nutrient starvation was regulated by 
a ULK1/Rab9 signalling axis independently of ATG7 [205]. However, it is unclear if Rab9 
function is mediated via ATG9a vesicle sorting and if Rab7 also contributes to mitophagy in 
this context. Interestingly, Rab9, together with SNX9, can regulate the formation of heat stress 
or LPS-induced MDVs to deliver mitochondrial cargo into the endo-lysosomal system. In 
contrast to ROS-induced MDVs that require PINK1 and Parkin [11], these Rab9-mediated 
MDVs were inhibited by PINK1/Parkin pathway activation. It is thought that this pathway is key 
in generating mitochondrial antigens (MitAP) to drive T-cell activation via MHC-I presentation 
[206]. 
 
4. Is mitophagy a viable therapeutic target? 
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The important power of mitophagy as a quality control mechanism for mitochondrial network 
homeostasis, cell integrity and organism development, comes as well with great responsibility. 
It is therefore not surprising that defects in mitophagy signalling have been associated with a 
plethora of common disorders with important social, medical and economic impact, for 
example, neurogenerative diseases, cardiovascular diseases and cancer [25,29]. Below we 
discuss the recent advances regarding mitophagy dysfunction in a neurogenerative context, 
in particular in relation to PD. However, our understanding of the physiological roles and 
implication of mitophagy in diseases, in general, remains limited.  
 
Over the past decades, the dysfunction of mitochondria has emerged as a potential common 
feature across multiple neurodegenerative diseases [207–210]. The low regenerative ability, 
high energy demand and large size of post-mitotic neuronal cells make them especially 
sensitive to loss of quality control mechanisms like autophagy or mitophagy [19,211,212]. 
Indeed, the decline of autophagic and proteasomal activity are hallmarks of ageing. Disruption 
of mitophagy, and the accumulation of dysfunctional mitochondria, has been hypothesised as 
one of the potential triggers of PD (and potentially Alzheimer’s [213]). This has been fostered 
by the familial forms of PD involving mutations in genes directly linked to mitophagy itself, 
such as PINK1 and Parkin. The majority of PD-related PINK1 and Parkin mutations challenge 
their activity or activation mechanism. For this reason, PINK1 and Parkin activators, or USP30 
DUB inhibitors, have emerged as potential therapeutic strategies to compensate for the loss 
of mitophagy [214]. However, the physiological contribution of PINK1 and Parkin in mitophagy 
is still not clear, as previously discussed in this review. Many studies on this pathway have 
been carried out in mice though, and it should be noted that PINK1 or Parkin knockout mice 
do not develop a classical neurodegenerative PD phenotype [215]. This is in contrast to rats 
lacking PINK1, which do exhibit age-dependent PD-pathological phenotypes [216]. Hence, 
PINK1/Parkin function with respect to PD could differ in mouse versus humans or rats. We 
note that non-human primate models for PINK1 may also provide important validation for this 
pathway [217]. It is therefore essential in the coming years to clarify the direct contribution 
PINK1 and Parkin in PD pathology and the contribution of mitophagy in general. It is possible 
that only a small subset of mitochondria needs to be turned over; hence any therapy must 
ensure that it is only these “unhealthy” mitochondria that are degraded to ensure exacerbation 
of the phenotype does not occur. Likewise, we currently do not know if a specific mitophagy 
pathway targets certain types of mitochondria; therefore it will be essential to activate the right 
mitophagy pathway at the right time. With respect to PD, it is also noteworthy that several 
other mutated genes such as LRRK2, VPS35 or Rab7L contribute to regulating membrane 
trafficking at various levels and may also impact upon mitophagy. Thus, the PINK1-Rab 
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signalling axis could harbour potential crosstalk with other endocytic-lysosome pathways with 
relevant contributions to the disease beyond mitophagy.  
 
New avenues of research indicate that loss of Parkin and PINK1 could drive PD pathogenesis 
through a neuroinflammation response. Matheoud et.al. unravelled a new mechanism, 
independent of classical mitophagy, where MDVs deliver mitochondrial proteins for turnover 
and MHC-I mitochondrial antigen presentation (MitAP) [206]. Though the physiological and 
pathological contribution of MitAP to disease in vivo remains to be confirmed, it was 
speculated that MitoAP is activated upon loss of PINK1 or Parkin and DA neurons become 
exposed to immune system-mediated elimination [206]. On a more classical mitophagy note, 
Sliter et. al. revealed that STING-mediated type 1 interferon response leads to stress-induced 
neurodegeneration in mice lacking of PINK1 or Parkin [103]. A failure to clear damaged 
mitochondria, caused by loss of PINK1 or Parkin, resulted in an increase in cytosolic and 
circulating mtDNA that triggered this inflammatory response. This inflammatory phenotype 
was only observed under dramatic acute and chronic stress, while depletion of PINK1 or 
Parkin failed to display an inflammatory response in mice at basal conditions [103]. Though 
the links between mitochondrial stress-driven inflammation and PD are important steps in the 
underlying pathology of PD, further research is still required to fully clarify the contribution of 
mitophagy during neuroinflammation and whether it is neuronal mitophagy that is most 
relevant. Indeed glial cells, such as microglia and astrocytes, which perform critical roles in 
brain homeostasis and neuroinflammation, undergo basal mitophagy in vivo [69]. 
Furthermore, astrocytes in the optic nerve were shown to coordinate transcellular mitophagy, 
where retinal ganglion cell axonal mitochondria are shuttled to neighbouring astrocytes for 
degradation [218]. This neuro-glial communication was also observed after cerebral 
ischaemia, where astrocytes released functional mitochondria to damaged neurons to ensure 
their survival [219]. Certainly, mitophagy in glial cells and neuro-glial interactions could have 
a critical contribution to neurodegenerative diseases that up-to-date has been largely 
overlooked.  
 
If mitophagy is validated as a viable therapeutic pathway, a big question remains as to what 
exactly to target. Several natural compounds have been reported to induce mitophagy and 
achieve anti-ageing and cytoprotective effects (i.e. Urolithin A, spermidine or Nicotinamide 
mononucleotides) [65,220–222]. In fact, the first-in-human clinical trial for Urolithin A has been 
recently published showing a transcriptional increase in some mitochondrial function, 
biogenesis and degradation markers from quadriceps muscles biopsies [223]. However, it is 
not clear if the anti-ageing effects associated with these compounds are only due to 
mitophagy. The chronic administration of these metabolites can result in a more boarder 
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impact on cell function or other aspects of mitochondria biology, including mitochondrial 
biogenesis. PINK1 and Parkin would be the obvious candidates to develop selective 
activators, but they are not essential for all forms of mitophagy, so may not be relevant for 
diseases outside of PD. Additionally, small molecule activators for PINK1 and Parkin would 
be of no use in patients that lack expression of these proteins, or at least have limited use in 
PD patients harbouring inactivating mutations in these genes. An alternative approach to 
directly targeting PINK1 and Parkin, and focussing on mitochondrial ubiquitylation more 
broadly, involves inhibiting USP30. Blocking USP30 would facilitate a faster and easier 
ubiquitylation of mitochondria to signal for mitophagy, which could compensate for a defective 
or reduced mitophagy activity. While USP30 has been primarily studied as a counterpart of 
PINK1/Parkin-mitophagy, its activity has been shown to also regulate basal mitophagy and 
pexophagy in vitro [147,224]. However, it is unclear how USP30 regulates mitophagy in a 
physiological or disease context, so more work is needed in this area. It may also be possible 
to enhance mitophagy by directly activating the autophagy initiation machinery, for example 
by pharmacological activation of ULK1, VPS34, AMPK or inhibition of mTORC1. Autophagy 
activation has been proposed as a potential therapeutic opportunity to enhance the clearance 
of protein aggregates in neurodegenerative disease or in cancer therapies [225]. However, 
aiming to activate the autophagy machinery to clear dysfunctional mitochondria will likely not 
be specific. Therefore, there are no clear therapeutic candidates to specifically modulate 
mitophagy yet. While most therapeutic efforts are focused on enhancing mitophagy, it cannot 
be excluded that upregulation of mitophagy could also have pathological implications. Indeed, 
evidence exists of deleterious upregulation of mitophagy such as in intracellular pathogen 
infection [167] or cancer cell survival during mitotic arrest [120].  
 
Conclusions: 
Significant advances have been achieved over the years to understand how mitophagy is 
regulated on a cellular basis. However, we are far from understanding how mitophagy 
signalling is regulated in vivo and its physiological contribution to diseases and organism 
development. Furthermore, the current data in the field suggests that mitophagy is more 
complex than anticipated. Mitophagy is not restricted to one or two signalling pathways; 
instead, it has an important contextual regulation with multiple signalling mechanisms, 
depending on the tissue, stress, metabolic state or development phase. In addition, mitophagy 
dynamism has to be framed under the light of mitochondrial network function and dynamics, 
where the orchestrated interplay of mitophagy with other mitochondrial quality control 
pathways remains unclear. Here, we aimed to review our current knowledge in order to answer 
basic questions about mitophagy: “What is it?”, “What is it used for?”, “Why is important?”, 
“How is regulated?” and “Can it be therapeutically useful?” By doing so, we have also 
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highlighted important gaps in our understating of mitophagy that indeed raise outstanding 
questions to resolve in the years to come. Now, more than ever before, we have the in vitro 
and in vivo tools to gain deeper insight on our understanding of mitophagy and its contribution 
to physiology and disease.   
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Figure legends: 
Figure 1: A timeline for mitophagy research. The chart shows the rapidly increasing number 
of publications identified as a “Journal Article” in a PubMed search for the term “mitophagy”. 
A selection of important contributions to the mitophagy field is highlighted across the timeline 
[226–228]. 
 
Figure 2: The molecular steps for mitochondrial degradation. Cartoon depicting the three 
steps required for mitochondrial degradation via mitophagy. A) Mitochondrion isolation or 
fission from the network, which can rely on DRP1 activity or the autophagy machinery. B) 
Marking or priming targeted mitochondria, which is mediated by ubiquitin-dependent or 
independent mitophagy receptors. C) Generation of the autophagosome and mitochondrion 
engulfment for degradation, which involves the recruitment of several factors such as 
autophagy receptors, the ULK1 complex and ATG9A-containing vesicles. Once the 
mitochondria are engulfed, the mitophagosome fuses with a lysosome to form the 
mitolysosome for the final elimination and recycling.  
 
Figure 3: Molecular mechanisms of mitophagy “eat-me” signals. Schematic cartoon 
summarising the main signalling events mediated by ubiquitin-dependent or independent 
mitophagosome recruitment. A) Ubiquitin-dependent mitophagy receptors (PINK1/Parkin 
mitophagy). (0): Basal levels of mitochondrial ubiquitylation is regulated by USP30 and an 
unknown E3-ligase. (1): Following mitochondrial depolarization, PINK1 is stabilised in the 
mitochondrial OMM and activated. This leads to phosphorylation of ubiquitin found on the 
OMM. (2): Parkin is recruited to the mitochondrion and activated by phospho-ubiquitin and 
PINK1 phosphorylation. (3) Activated Parkin starts ubiquitylating OMM proteins. Other E3-
ligases have been described to cooperate or work independently of Parkin at this step. (4): 
Generation of ubiquitin chains lead to the recruitment of autophagy receptors like NDP52, 
OPTN or p62. Phospho-ubiquitin can also directly recruit autophagy receptors. In parallel, 
TBK1 is recruited and activated by an unknown kinase. TBK1 phosphorylates OPTN, which 
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strengthens the interaction with ubiquitin chains. (5): ULK1 complex and other 
autophagosome biogenesis machinery are recruited by autophagy receptors. Autophagy 
receptors interact with LC3/GABARAP proteins coating the forming phagophore. (6) Upon 
mitochondria depolarization, NIPSNAP1/2 are no longer translocated to the mitochondrial 
matrix and mediate direct recruitment of autophagy receptors. (7) Downstream of Parkin 
activity, the OMM is broken to expose PHB2 from the IMM. PHB2 acts as mitophagy receptor 
and interacts with LC3/GABARAP proteins. (8) OMMAD mediated by Parkin and other E3-
ligases trigger the proteasomal degradation of mitochondrial proteins including MIRO1 or 
Mitofusin1/2 (MFN), affecting mitochondria fusion and transport. B) Ubiquitin-independent 
mitophagy receptors, which recruit the phagophore by direct interaction with LC3/GABARAP 
proteins from the mitochondrial OMM. (1) FUNDC1 function is inhibited by CK2 and Src 
kinases phosphorylation of its LIR motif. Once mitophagy is triggered, PGAM5 phosphatase 
dephosphorylates FUNDC1 to facilitate its interaction with LC3. ULK1 also phosphorylates 
FUNDC1 to strengthen the interaction with the phagophore. (2) Cardiolipin and Ceramides 
translocate OMM to interact with LC3. NIX and BNIP3 are upregulated by HIF1 a and 
accumulate in the OMM to mediate mitophagy (3) In macrophages, NLRX1 mitochondrial 
receptor is activated by listeriolysin O virulence factor after Listeria infection. (4) BCL2L13 
interacts with ULK1 complex and LC3 proteins to mediate mitophagy. In yeast, the mitophagy 
receptor ATG32 is phosphorylated by CK2 to promote ATG11 interaction, which leads to 
association with ATG8 and recruitment of mitochondria to the phagophore assembly site 
(PAS). 
 
Figure 4: Mitophagy-related roles of the Rab7 GTPase. (A) Rab7 recycling from lysosomes 
is mediated by retromer complex, providing an accessible pool of inactive Rab7 which can 
then be recruited to the OMM following Parkin activation. This is achieved by binding of the 
Rab5 GEF (RabGEF) to ubiquitylated substrates in the OMM, which triggers the canonical 
Rab5-Rab7 conversion cascade that results in Rab7 localisation. Active mitochondrial Rab7 
is phosphorylated by TBK1, which facilitates the recruitment of ATG9A vesicles for 
phagophore expansion. Active Rab7 also recruits FNIP1/2 and FLCN, which are required for 
mitophagy through an unknown function. Mitochondrial Rab7 is inactivated by TBC1D15/17, 
which are recruited to mitochondria by Fis1. B) Rab9, SNX9 and Rab7 facilitate mitochondria 
antigen presentation (mitAP) via MDV vesicles. Rab9, localised at the TGN and late 
endosome, regulates the formation of ATG9A positive vesicles to form the phagophore 
independently of the ATG8 conjugating system.  
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